392 related articles for article (PubMed ID: 32575921)
1. OMV Vaccines and the Role of TLR Agonists in Immune Response.
Mancini F; Rossi O; Necchi F; Micoli F
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
[TBL] [Abstract][Full Text] [Related]
3. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
[TBL] [Abstract][Full Text] [Related]
4. Outer membrane vesicles as platform vaccine technology.
van der Pol L; Stork M; van der Ley P
Biotechnol J; 2015 Sep; 10(11):1689-706. PubMed ID: 26912077
[TBL] [Abstract][Full Text] [Related]
5. Outer Membrane Vesicle Vaccine Platforms.
Micoli F; Adamo R; Nakakana U
BioDrugs; 2024 Jan; 38(1):47-59. PubMed ID: 37796436
[TBL] [Abstract][Full Text] [Related]
6. Bacterial outer membrane vesicles induce a transcriptional shift in arabidopsis towards immune system activation leading to suppression of pathogen growth in planta.
Chalupowicz L; Mordukhovich G; Assoline N; Katsir L; Sela N; Bahar O
J Extracell Vesicles; 2023 Jan; 12(1):e12285. PubMed ID: 36645092
[TBL] [Abstract][Full Text] [Related]
7. Outer Membrane Vesicle-Host Cell Interactions.
Cecil JD; Sirisaengtaksin N; O'Brien-Simpson NM; Krachler AM
Microbiol Spectr; 2019 Jan; 7(1):. PubMed ID: 30681067
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of
Croia L; Boscato Sopetto G; Zanella I; Caproni E; Gagliardi A; Tamburini S; König E; Benedet M; Di Lascio G; Corbellari R; Grandi A; Tomasi M; Grandi G
Membranes (Basel); 2023 Nov; 13(11):. PubMed ID: 37999368
[TBL] [Abstract][Full Text] [Related]
9. Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors.
Zheng K; Feng Y; Li L; Kong F; Gao J; Kong X
Theranostics; 2024; 14(2):761-787. PubMed ID: 38169585
[TBL] [Abstract][Full Text] [Related]
10. Anti-EGFR bioengineered bacterial outer membrane vesicles as targeted immunotherapy candidate in triple-negative breast tumor murine model.
Rezaei Adriani R; Mousavi Gargari SL; Bakherad H; Amani J
Sci Rep; 2023 Sep; 13(1):16403. PubMed ID: 37775519
[TBL] [Abstract][Full Text] [Related]
11. Induced fusion and aggregation of bacterial outer membrane vesicles: Experimental and theoretical analysis.
Gnopo YMD; Misra A; Hsu HL; DeLisa MP; Daniel S; Putnam D
J Colloid Interface Sci; 2020 Oct; 578():522-532. PubMed ID: 32540551
[TBL] [Abstract][Full Text] [Related]
12. Glycoconjugates of Gram-negative bacteria and parasitic protozoa - are they similar in orchestrating the innate immune response?
Karaś MA; Turska-Szewczuk A; Janczarek M; Szuster-Ciesielska A
Innate Immun; 2019 Jan; 25(1):73-96. PubMed ID: 30782045
[TBL] [Abstract][Full Text] [Related]
13. Surface Mineralization of Engineered Bacterial Outer Membrane Vesicles to Enhance Tumor Photothermal/Immunotherapy.
Chen X; Li P; Luo B; Song C; Wu M; Yao Y; Wang D; Li X; Hu B; He S; Zhao Y; Wang C; Yang X; Hu J
ACS Nano; 2024 Jan; 18(2):1357-1370. PubMed ID: 38164903
[TBL] [Abstract][Full Text] [Related]
14. Outer Membrane Vesicles Derived From
Lee J; Yoon YJ; Kim JH; Dinh NTH; Go G; Tae S; Park KS; Park HT; Lee C; Roh TY; Di Vizio D; Gho YS
Front Microbiol; 2018; 9():2268. PubMed ID: 30369908
[TBL] [Abstract][Full Text] [Related]
15. Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle-based vaccine platform, for efficient viral antigen delivery.
Hu K; Palmieri E; Samnuan K; Ricchetti B; Oldrini D; McKay PF; Wu G; Thorne L; Fooks AR; McElhinney LM; Goharriz H; Golding M; Shattock RJ; Micoli F
J Extracell Vesicles; 2022 Nov; 11(11):e12247. PubMed ID: 36377074
[TBL] [Abstract][Full Text] [Related]
16. Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy.
Park KS; Svennerholm K; Crescitelli R; Lässer C; Gribonika I; Lötvall J
J Extracell Vesicles; 2021 Jul; 10(9):e12120. PubMed ID: 34262675
[TBL] [Abstract][Full Text] [Related]
17. Metal-polyphenol "prison" attenuated bacterial outer membrane vesicle for chemodynamics promoted in situ tumor vaccines.
Nie W; Jiang A; Ou X; Zhou J; Li Z; Liang C; Huang LL; Wu G; Xie HY
Biomaterials; 2024 Jan; 304():122396. PubMed ID: 38043464
[TBL] [Abstract][Full Text] [Related]
18. Identifying size-dependent toxin sorting in bacterial outer membrane vesicles.
Singh AN; Nice JB; Brown AC; Wittenberg NJ
bioRxiv; 2023 May; ():. PubMed ID: 37205353
[TBL] [Abstract][Full Text] [Related]
19. Application of Outer Membrane Protein-Based Vaccines Against Major Bacterial Fish Pathogens in India.
Maiti B; Dubey S; Munang'andu HM; Karunasagar I; Karunasagar I; Evensen Ø
Front Immunol; 2020; 11():1362. PubMed ID: 32849496
[TBL] [Abstract][Full Text] [Related]
20. Multivariate Analysis of Individual Bacterial Outer Membrane Vesicles Using Fluorescence Microscopy.
Singh AN; Nice JB; Wu M; Brown AC; Wittenberg NJ
Chem Biomed Imaging; 2024 May; 2(5):352-361. PubMed ID: 38817321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
